Form 4: Exact Sciences Corp Executive Jacob A. Orville Reports Stock Transactions
SEC Form 4
EVP Jacob A. Orville reports stock transactions related to vesting of restricted stock units.
Summary
- Jacob A. Orville, EVP, GM, Screening at Exact Sciences Corp, reported transactions involving common stock and restricted stock units on February 28, 2025.
- These transactions include the vesting of restricted stock units, the acquisition of common stock upon vesting, and the disposal of common stock for tax withholding.
- Orville received 4,725 shares and 4,948 shares of common stock upon vesting of restricted stock units.
- A total of 2,221 and 2,326 shares were withheld by Exact Sciences for tax purposes at a price of $47.82 per share.
- Following these transactions, Orville directly owns 25,402 shares of common stock and indirectly owns 1,490 shares held in a 401(k) plan.
- He also holds 9,450 and 14,845 restricted stock units and 85,011 vested and unvested options to purchase shares of common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive stock transactions, and it doesn't inherently convey positive or negative sentiment. It's a neutral disclosure of information.
Positives
- The vesting of restricted stock units indicates that Orville is meeting performance or time-based milestones set by the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the biotechnology and healthcare industries, used to align executive incentives with shareholder value.
- Companies like Illumina, Inc. (ILMN) and Genomic Health (now part of Exact Sciences) also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedules and tax withholding practices described in the filing are typical for these types of equity awards.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily reflect the execution of existing compensation plans.
- Shareholders may view insider ownership as a positive sign, aligning management's interests with their own.
Key Dates
| Date | Description |
|---|---|
| 2023-02-24 | Date of restricted stock unit award that partially vested on February 28, 2025. |
| 2024-02-26 | Date of restricted stock unit award that partially vested on February 28, 2025. |
| 2025-02-28 | Date of transactions: vesting of restricted stock units, acquisition of common stock, and disposal of common stock for tax withholding. |
| 2025-03-04 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.